Injection in the Treatment of Lateral Epicondylitis. Randomized Controlled Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 1, 2023

Study Completion Date

January 1, 2023

Conditions
Epicondylitis, Lateral
Interventions
DRUG

plate-rich plasma

1ml prp (plate-rich plasma to be prepared with the blood taken from the patient on the day of injection), , while the patient is in the supine position, the affected elbow is 90 flexion and neutral rotation, The non-dominant thumb will be placed at the sensitive point in the lateral epicondyle. The injection will be applied to the point with a 23 g needle. After the injection, the subjects will be taught a stretching exercise of the joint extensors of the wrist and fingers. Subjects will be asked to do this exercise five times in one session, two sessions a day

DRUG

saline (0.9 NACI)

1 ml saline (0.9 NACI) while the patient is in the supine position, the affected elbow is 90 flexion and neutral rotation, The non-dominant thumb will be placed at the sensitive point in the lateral epicondyle. The injection will be applied to the point with a 23 g needle. After the injection, the subjects will be taught a stretching exercise of the joint extensors of the wrist and fingers. Subjects will be asked to do this exercise five times in one session, two sessions a day

DRUG

betametazon

1 ml betametazon while the patient is in the supine position, the affected elbow is 90 flexion and neutral rotation, The non-dominant thumb will be placed at the sensitive point in the lateral epicondyle. The injection will be applied to the point with a 23 g needle. After the injection, the subjects will be taught a stretching exercise of the joint extensors of the wrist and fingers. Subjects will be asked to do this exercise five times in one session, two sessions a day

Trial Locations (1)

Unknown

Istanbul University, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER

NCT04875338 - Injection in the Treatment of Lateral Epicondylitis. Randomized Controlled Trial | Biotech Hunter | Biotech Hunter